•  
  •  
  •  
  •  

2022-05-17 13:15:43

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Indoco Remedies Ltd recommends dividend of Rs. 2.25
  • Zydus Wellness Ltd recommends final dividend of Rs. 5
  • Datamatics signs Automatic Fare Collection contract for Delhi-Meerut RRTS Corridor of NCRTC
  • Bajaj Electricals Ltd Q4 FY2022 consolidated profit declines to Rs. 39.35 crores
  • Indoco Remedies Q4FY22 consolidated PAT higher at Rs. 40.45 crores

Keywords Selected:  Pharmaceuticals

Research

  • Quant Pick - Cadila Healthcare - ICICI Direct
  • Q2FY22 Result Update - Syngene International - ICICI Direct
  • Syngene International Ltd - Lack of near term triggers - YES Securities
  • Syngene International Ltd - Lower gross margin lead to EBIDTA miss - YES Securities

Stock Report

  • Fredun Pharmaceuticals Ltd Board recommends final dividend of Rs. 0.70
  • GlaxoSmithKline Pharmaceuticals Ltd recommends dividend of Rs. 90
  • Fredun Pharmaceuticals posts net profit of Rs. 2.29 crores in Q4FY22
  • GlaxoSmithKline Pharmaceuticals Ltd Q4FY22 consolidated profit at Rs. 1219.05 crores
  • Alembic Pharmaceuticals receives USFDA final approvl for Arformoterol Tartrate Inhalation Solution
  • Suven Pharmaceuticals Q4 FY2022 consolidated PAT slides QoQ to Rs. 91.66 crores
  • Suven Pharmaceuticals Limited declares 2nd interim dividend of Rs. 1
  • Glenmark Pharmaceuticals receives tentative ANDA approval for Calcipotriene and Betamethasone Dipropionate Foam, 0.005%, 0.064%
  • Aleor Dermaceuticals receives USFDA Final Approval for Docosanol Cream, 10% (OTC)
  • Alembic Pharmaceuticals Q4FY22 consolidated PAT declines to Rs. 35.46 crores
  • Alembic Pharmaceuticals Ltd Board recommends Dividend of Rs. 10
  • India Ratings Upgrades Torrent Pharmaceuticals and its NCDs to 'IND AA+', Outlook Stable
  • Glenmark receives the 'India Pharma Innovation of the Year' Award from the Government of India
  • Aleor Dermaceuticals Limited receives USFDA Final Approval for Clobetasol Propionate Foam, 0.05%
  • Glenmark to launch Drug for Type 2 Diabetes in India
  • IOL Chemicals and Pharmaceuticals Ltd commences commercial production of Paracetamol
  • Alembic Pharmaceuticals receives USFDA Tentative Approval for Ivabradine Tablets, 5 mg and 7.5 mg
  • Earum Pharmaceuticals Q4FY22 net loss at Rs. 71.60 lakhs
  • Aleor Dermaceuticals Limited receives USFDA Final Approval for Lidocaine and Prilocaine Cream USP, 2.5%/2.5%
  • Glenmark Specialty S.A. receives approval for conducting Phase 1 Clinical Trial of its Novel Molecule GRC 54276
  • Alembic Pharmaceuticals gets USFDA Tentative Approval for Dabigatran Etexilate Capsules
  • Suven Pharmaceuticals approves acquisition of Casper Pharma Pvt Ltd
  • Lupin Enters into Licensing Agreement with Alvion to market Cardiometabolic Drugs in the Southeast Asia region
  • Jenburkt Wellness Launches D2C Brand Zixa Strong

Latest Post

  • Indoco Remedies Ltd recommends dividend of Rs. 2.25
  • Zydus Wellness Ltd recommends final dividend of Rs. 5
  • Datamatics signs Automatic Fare Collection contract for Delhi-Meerut RRTS Corridor of NCRTC
  • Bajaj Electricals Ltd Q4 FY2022 consolidated profit declines to Rs. 39.35 crores
  • Indoco Remedies Q4FY22 consolidated PAT higher at Rs. 40.45 crores


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
No:AP-172, 2nd Sector, 10th Street, KK Nagar
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-80560-88967
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

Disclaimer Copyright © - 2021